Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
68 participants
INTERVENTIONAL
2026-04-30
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will be randomized to use new educational materials or current existing educational materials and answer survey questions.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients at the University of Utah Thrombosis Clinic will be recruited.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Care
Standard Educational process
Control Group: Standard of Care
This will be the current practice for patient education
Education Intervention
New educational intervention
Anticoagulation Educational Materials
This includes new web-based patient educational materials that have been developed prior to the start of the study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anticoagulation Educational Materials
This includes new web-based patient educational materials that have been developed prior to the start of the study
Control Group: Standard of Care
This will be the current practice for patient education
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experienced patients will be eligible if they score less than 75% on the Anticoagulation Knowledge Test
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aubrey E. Jones
Assistant Research Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aubrey E Jones, PharmD, MSCI
Role: PRINCIPAL_INVESTIGATOR
University of Utah
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB_00146488
Identifier Type: -
Identifier Source: org_study_id